X-10185110-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 0P and 11B. BP4_StrongBP6_ModerateBP7BS2
The NM_001830.4(CLCN4):c.78G>A(p.Thr26Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000159 in 1,208,033 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 72 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.00022 ( 0 hom., 14 hem., cov: 23)
Exomes 𝑓: 0.00015 ( 0 hom. 58 hem. )
Consequence
CLCN4
NM_001830.4 synonymous
NM_001830.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -4.73
Genes affected
CLCN4 (HGNC:2022): (chloride voltage-gated channel 4) The CLCN family of voltage-dependent chloride channel genes comprises nine members (CLCN1-7, Ka and Kb) which demonstrate quite diverse functional characteristics while sharing significant sequence homology. Chloride channel 4 has an evolutionary conserved CpG island and is conserved in both mouse and hamster. This gene is mapped in close proximity to APXL (Apical protein Xenopus laevis-like) and OA1 (Ocular albinism type I), which are both located on the human X chromosome at band p22.3. The physiological role of chloride channel 4 remains unknown but may contribute to the pathogenesis of neuronal disorders. Alternate splicing results in two transcript variants that encode different proteins. [provided by RefSeq, Mar 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -11 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.76).
BP6
Variant X-10185110-G-A is Benign according to our data. Variant chrX-10185110-G-A is described in ClinVar as [Benign]. Clinvar id is 697048.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-4.73 with no splicing effect.
BS2
High Hemizygotes in GnomAd4 at 14 XL gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000224 AC: 25AN: 111649Hom.: 0 Cov.: 23 AF XY: 0.000414 AC XY: 14AN XY: 33845
GnomAD3 genomes
AF:
AC:
25
AN:
111649
Hom.:
Cov.:
23
AF XY:
AC XY:
14
AN XY:
33845
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000482 AC: 88AN: 182557Hom.: 0 AF XY: 0.000507 AC XY: 34AN XY: 67015
GnomAD3 exomes
AF:
AC:
88
AN:
182557
Hom.:
AF XY:
AC XY:
34
AN XY:
67015
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000152 AC: 167AN: 1096331Hom.: 0 Cov.: 29 AF XY: 0.000160 AC XY: 58AN XY: 361751
GnomAD4 exome
AF:
AC:
167
AN:
1096331
Hom.:
Cov.:
29
AF XY:
AC XY:
58
AN XY:
361751
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000224 AC: 25AN: 111702Hom.: 0 Cov.: 23 AF XY: 0.000413 AC XY: 14AN XY: 33908
GnomAD4 genome
AF:
AC:
25
AN:
111702
Hom.:
Cov.:
23
AF XY:
AC XY:
14
AN XY:
33908
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 24, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at